Menu Search
Equities

Immunocore Holdings PLC

IMCR:NSQ

Immunocore Holdings PLC

Actions
  • Price (USD)34.21
  • Today's Change-0.23 / -0.67%
  • Shares traded308.49k
  • 1 Year change-33.33%
  • Beta0.7386
Data delayed at least 15 minutes, as of Sep 19 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Sep-23
  • 20-Jun-24
  • 18-Jul-24
  • 15-Aug-24
  • 16-Sep-24
Select bar for recommendation details.
Recommendations16-Sep-24
Buy7
Outperform10
Hold0
Sell0
Strong Sell0

Share price forecast in USD

The 15 analysts offering 12 month price targets for Immunocore Holdings PLC - ADR have a median target of 80.00, with a high estimate of 100.00 and a low estimate of 66.00. The median estimate represents a 133.85% increase from the last price of 34.21.
High192.3%100.00
Med133.8%80.00
Low92.9%66.00

Earnings history & estimates in USD

On Aug 08, 2024, Immunocore Holdings PLC - ADR reported 2nd quarter 2024 losses of -0.23 per share. This result exceeded the -0.48 consensus loss of the 17 analysts covering the company and exceeded last year's 2nd quarter results by 37.50%.
The next earnings announcement is expected on Nov 05, 2024.
Average growth rate+15.28%
Immunocore Holdings PLC - ADR reported annual 2023 losses of -1.13 per share on Feb 28, 2024.
Average growth rate+20.11%
More ▼

Revenue history & estimates in USD

Immunocore Holdings PLC - ADR had 2nd quarter 2024 revenues of 75.35m. This bettered the 74.58m consensus of the 16 analysts covering the company. This was 37.16% above the prior year's 2nd quarter results.
Average growth rate+5.64%
Immunocore Holdings PLC - ADR had revenues for the full year 2023 of 249.43m. This was 43.45% above the prior year's results.
Average growth rate+138.40%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.